Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immune Assessment of BNT162b2 m-RNA-Spike Based Vaccine Response in Adults.
San Segundo D, Comins-Boo A, Irure-Ventura J, Renuncio-García M, Roa-Bautista A, González-López E, Merino-Fernández D, Lamadrid-Perojo P, Alonso-Peña M, Ocejo-Vinyals JG, Gutiérrez-Larrañaga M, Guiral-Foz S, López-Hoyos M. San Segundo D, et al. Among authors: gutierrez larranaga m. Biomedicines. 2021 Jul 22;9(8):868. doi: 10.3390/biomedicines9080868. Biomedicines. 2021. PMID: 34440072 Free PMC article.
High prevalence of cryofibrinogenemia in patients with chilblains during the COVID-19 outbreak.
Gómez-Fernández C, López-Sundh AE, González-Vela C, Ocejo-Vinyals JG, Mayor-Ibarguren A, Salas-Venero CA, Gutiérrez-Larrañaga M, Tejerina-Puente A, Fariñas MC, Cabero-Pérez MJ, López-Hoyos M, González-López MA. Gómez-Fernández C, et al. Among authors: gutierrez larranaga m. Int J Dermatol. 2020 Dec;59(12):1475-1484. doi: 10.1111/ijd.15234. Epub 2020 Oct 17. Int J Dermatol. 2020. PMID: 33070314
Validation of a Quick Flow Cytometry-Based Assay for Acute Infection Based on CD64 and CD169 Expression. New Tools for Early Diagnosis in COVID-19 Pandemic.
Comins-Boo A, Gutiérrez-Larrañaga M, Roa-Bautista A, Guiral Foz S, Renuncio García M, González López E, Irure Ventura J, Fariñas-Álvarez MC, San Segundo D, López Hoyos M. Comins-Boo A, et al. Among authors: gutierrez larranaga m. Front Med (Lausanne). 2021 Mar 23;8:655785. doi: 10.3389/fmed.2021.655785. eCollection 2021. Front Med (Lausanne). 2021. PMID: 33869256 Free PMC article.
Immune Checkpoint Inhibitors: The Emerging Cornerstone in Cholangiocarcinoma Therapy?
Gutiérrez-Larrañaga M, González-López E, Roa-Bautista A, Rodrigues PM, Díaz-González Á, Banales JM, López-Hoyos M, Santos-Laso A, Crespo J. Gutiérrez-Larrañaga M, et al. Liver Cancer. 2021 Sep 21;10(6):545-560. doi: 10.1159/000518104. eCollection 2021 Nov. Liver Cancer. 2021. PMID: 34950178 Free PMC article. Review.
Clinical and immunological study of Tofacitinib and Baricitinib in refractory Blau syndrome: case report and literature review.
Álvarez-Reguera C, Prieto-Peña D, Herrero-Morant A, Sánchez-Bilbao L, Martín-Varillas JL, González-López E, Gutiérrez-Larrañaga M, San Segundo D, Demetrio-Pablo R, Ocejo-Vinyals G, González-Gay MA, Blanco R. Álvarez-Reguera C, et al. Among authors: gutierrez larranaga m. Ther Adv Musculoskelet Dis. 2022 Apr 29;14:1759720X221093211. doi: 10.1177/1759720X221093211. eCollection 2022. Ther Adv Musculoskelet Dis. 2022. PMID: 35510170 Free PMC article.
Non-HLA Antibodies and Their Role in Highly Sensitized Patients.
Roa-Bautista A, López-Del-Moral C, González-López E, Gutiérrez-Larrañaga M, Renuncio-García M, Castro-Hernández C, Mikhalkovich-Mikhalkovich D, Comins-Boo A, Irure-Ventura J, Rodrigo E, Ruiz San Millán JC, López-Hoyos M, San Segundo D. Roa-Bautista A, et al. Among authors: gutierrez larranaga m. Transplant Proc. 2022 Nov;54(9):2439-2442. doi: 10.1016/j.transproceed.2022.10.011. Epub 2022 Oct 29. Transplant Proc. 2022. PMID: 36319497
Estimation of Antibody-Verified Eplet Mismatch Load, 2-Field HLA Resolution vs Imputation in a Large Cohort of European Donors.
Renuncio-García M, González-López E, Carreras E, Villa J, Romón-Alonso I, Roa-Bautista A, Gutiérrez-Larrañaga M, Comins-Boo A, Irure-Ventura J, López-Hoyos M, San Segundo D. Renuncio-García M, et al. Among authors: gutierrez larranaga m. Transplant Proc. 2022 Nov;54(9):2414-2418. doi: 10.1016/j.transproceed.2022.09.011. Epub 2022 Nov 1. Transplant Proc. 2022. PMID: 36333253
Molecular Mechanisms of Cholangiocarcinogenesis: New Potential Targets for Therapy.
Erice O, Merino-Azpitarte M, Arbelaiz A, Gutierrez-Larranaga M, Jimenez-Aguero R, Perugorria MJ, Bujanda L, Banales JM. Erice O, et al. Among authors: gutierrez larranaga m. Curr Drug Targets. 2017;18(8):932-949. doi: 10.2174/1389450116666150825113035. Curr Drug Targets. 2017. PMID: 26302803 Review.